title: Clinical utility of ANA measured by ELISA compared with ANA measured by immunofluorescence.
authors.forename: Gerald A
authors.initials: GA
authors.lastname: Maguire
authors.forename: Amel
authors.initials: A
authors.lastname: Ginawi
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Lee
authors.forename: Anita Y N
authors.initials: AY
authors.lastname: Lim
authors.forename: Graham
authors.initials: G
authors.lastname: Wood
authors.forename: Sally
authors.initials: S
authors.lastname: Houghton
authors.forename: Dinakantha S
authors.initials: DS
authors.lastname: Kumararatne
authors.forename: Hill J S
authors.initials: HJ
authors.lastname: Gaston
mesh_terms: D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000097:blood*; D016022:Case-Control Studies; D003240:Connective Tissue Diseases / Q000175:diagnosis*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D008297:Male; D008875:Middle Aged; D012680:Sensitivity and Specificity
chemical_list: D000974:Antibodies, Antinuclear